|
|
|
The GHS Team
Genomic Healthcare Strategies has assembled a team of senior professionals whose skills complement one another. We combine strong capabilities in strategy, commercial, and entrepreneurial experience with great depth in science. Our project teams are made up of experienced senior staff to provide the mix of skills our clients need.
Keith F. Batchelder, MD, CEO is the founder and CEO of Genomic Healthcare Strategies, a company focused on the changes in healthcare resulting from advances in molecular medicine. Dr. Batchelder has long been interested in the intersection of the scientific, business and societal promises and challenges raised by personalized medicine.
More about Keith Batchelder >>
Peter S. Miller, COO is Chief Operating Officer of Genomic Healthcare Strategies, a company focused on the changes in healthcare resulting from advances in molecular medicine. He brings a track record of success, combining strategic skills, senior operations experience, sales and marketing success, project management, and merger/acquisition experience.
More about Peter Miller >>
Richard Gill, PhD has over 28 years of strategic management, research, and technology commercialization experience in the life sciences industry.
More about Richard Gill >>
Steve Herbert has helped build some of the most successful companies to emerge from the fertile intersection of science and information technology in the areas of molecular modeling, combinatorial chemistry, bioinformatics and statistics.
More about Steve Herbert >>
Leslie J. Williams has more than 20 years of industry experience in healthcare, management, commercial product development and marketing. Her two decades-plus career runs the gamut from nursing to corporate executive leadership positions, including president and chief executive officer of Ventaira Pharmaceuticals.
More about Leslie Williams >>
The GHS Advisory Board is composed of leaders in health care, science, business, and ethics. GHS calls on them for advice and counsel about important issues around our work.
More about the Advisory Board >>
|
|
|
